HSV-2 transmission.
Sacks
S L
SL
Viridae, Vancouver, Canada.
Griffiths
P D
PD
Corey
L
L
Cohen
C
C
Cunningham
A
A
Dusheiko
G M
GM
Self
S
S
Spruance
S
S
Stanberry
L R
LR
Wald
A
A
Whitley
R J
RJ
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D006558:Herpes Genitalis / Q000517:prevention & control / Q000635:transmission* / Q000821:virology*; D018258:Herpesvirus 2, Human / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000821:virology; D012307:Risk Factors; D012725:Sexual Behavior; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D017201:Virus Shedding / Q000187:drug effects*
D000998:Antiviral Agents; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir